Sage Therapeutics Inc. sell me8
Start price
07.08.23
/
0%
€15.10
Target price
07.08.24
-
Performance (%)
21.19%
End price
18.08.23
€18.30
Summary
This prediction ended on 18.08.23 with a price of €18.30. The prediction closed with a disappointing performance of 21.19%. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Sage Therapeutics Inc. | 7.851% | 7.851% |
| iShares Core DAX® | -0.992% | -3.231% |
| iShares Nasdaq 100 | -0.225% | -3.339% |
| iShares Nikkei 225® | -0.736% | -7.859% |
| iShares S&P 500 | -0.509% | -2.979% |
According to me8 what are the pros and cons of Sage Therapeutics Inc. for the foreseeable future?
Pros
Capable Management
Cons
Risky Investment
No uniques
Comments by me8 for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sell Sage Therapeutics Inc.